JOHNSON & JOHNSON 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
JJ JOHNSON & JOHNSON | Institutional Filer | ▲ 17.62% | $652.4M | 16 |
Current Portfolio Holdings
Showing all 16 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | PTGX | Protagonist Therapeutics, Inc. | Healthcare | 2.4M | $258.1M | 39.57% |
| 2 | NBTX | Nanobiotix S.A. | Healthcare | 5.6M | $173.6M | 26.61% |
| 3 | MGTX | MeiraGTx Holdings plc | Healthcare | 6.6M | $57.5M | 8.82% |
| 4 | RAPP | Rapport Therapeutics, Inc. Common Stock | Healthcare | 1.8M | $55.8M | 8.56% |
| 5 | CVRX | CVRx, Inc. | Healthcare | 4.0M | $38.1M | 5.84% |
| 6 | CTNM | Contineum Therapeutics, Inc. Class A Common Stock | Healthcare | 2.0M | $25.8M | 3.96% |
| 7 | LEGN | Legend Biotech Corporation | Healthcare | 815K | $14.7M | 2.26% |
| 8 | XNCR | Xencor, Inc. | Healthcare | 748K | $9.0M | 1.38% |
| 9 | PRCT | PROCEPT BioRobotics Corporation | Healthcare | 358K | $9.0M | 1.37% |
| 10 | FATE | Fate Therapeutics, Inc. | Healthcare | 3.4M | $4.1M | 0.62% |
| 11 | NMRA | Neumora Therapeutics, Inc. Common Stock | Healthcare | 1.8M | $3.6M | 0.55% |
| 12 | RLYB | Rallybio Corporation | Healthcare | 153K | $1.4M | 0.21% |
| 13 | VOR | Vor Biopharma Inc. | Healthcare | 54K | $959K | 0.15% |
| 14 | LAB | Standard BioTools Inc. | Healthcare | 312K | $287K | 0.04% |
| 15 | NNOX | Nano-X Imaging Ltd. | Healthcare | 84K | $190K | 0.03% |
Showing 1 to 15 of 16 holdings